drugset / Trial / NCT01639222
Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that the intestinal absorption of calcium from a newly developed calcium carbonate-vitamin D3 chewable tablet formulation increases the amount of calcium excreted in urine and decreases parathyroid hormone (PTH) in serum as compared to baseline.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcium carbonate | Other / unclassified | 500 mg | Oral |
| Subject | Cholecalciferol | Other / unclassified | 800 iu | Oral |